Cargando…
Bisphosphonate therapy in otosclerosis: A scoping review
OBJECTIVE: Otosclerosis, a leading cause of deafness in adults, results from defective bone remodeling of the otic capsule. Bisphosphonates have been used to decrease bone remolding in many diseases, including otosclerosis. This study analyzes whether current literature supports bisphosphonate thera...
Autores principales: | Zimmerer, René E., Africa, Robert E., Westenhaver, Zack K., McKinnon, Brian J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823176/ https://www.ncbi.nlm.nih.gov/pubmed/35155804 http://dx.doi.org/10.1002/lio2.729 |
Ejemplares similares
-
Third‐generation bisphosphonates for cochlear otosclerosis stabilizes sensorineural hearing loss in long‐term follow‐up
por: Jan, Taha A., et al.
Publicado: (2017) -
Otopathology Findings in Otosclerosis With Lateral Semicircular Canal Fenestration
por: Dewyer, Nicholas A., et al.
Publicado: (2019) -
Psychometric properties of the Swedish version of the Glasgow Benefit Inventory in otosclerosis subjects
por: Redfors, Ylva Dahlin, et al.
Publicado: (2019) -
Facial nerve stimulation in adult cochlear implant recipients with far advanced otosclerosis
por: Tuset, Maria‐Pia, et al.
Publicado: (2022) -
A rare entity: Benign osteonecrosis of the temporal bone
por: Whittaker, Alexandra G., et al.
Publicado: (2022)